Hyperbaric Radiation Sensitization of Head and Neck Cancers
Squamous Cell Carcinoma of the Head and Neck
About this trial
This is an interventional treatment trial for Squamous Cell Carcinoma of the Head and Neck focused on measuring Hyperbaric oxygen; HNSCC; Radiotherapy; Chemotherapy
Eligibility Criteria
Inclusion Criteria:
- Patients with histological or microscopic proof (from the primary tumor and/or lymph nodes) of invasive squamous cell carcinoma of the oral cavity, oropharynx or larynx (World Health Organization type 1).
- Stage III or IV disease, M0
- Non-surgical candidate; for reasons of health or age (except biopsy)
- Human Papillomavirus (P16) negative
- Life expectancy of at least 6 months and a Karnofsky performance status of ≥ 70
- Age ≥ 18 years
- No distant metastatic disease
No clinically significant heart disease:
No significant ventricular arrhythmia requiring medication with antiarrhythmic. No symptomatic coronary artery disease (angina). No myocardial infarction within the last 6 months. No second or third degree heart block or bundle branch block or clinically significant conduction system abnormality.
- Patients must sign a study-specific informed consent form
Exclusion Criteria:
- Histology other than squamous cell carcinoma
- Evidence of metastasis (below the clavicle or distant) by clinical or radiographic means
- History of prior invasive malignancy, unless at least 5 years without evidence of recurrence (tumor-specific restaging)
- Prior resection of the primary tumor or lymph node, unless un-operated N2-N3 nodal disease or primary tumor remaining, respectively.
- Prior chemotherapy for head and neck cancer or radiotherapy to the head and neck
- Prior treatment with Bleomycin
- Creatinine clearance: measured or estimated Glomerular Filtration Rate <40 ml/min.
- Patients with simultaneous primaries
- Pregnancy
- Participating in a conflicting protocol
Pulmonary pathologies (risk of decompression-induced pulmonary barotrauma)
Current, untreated pneumothorax. Previous history of spontaneous pneumothorax. Previous history of intrathoracic surgery. History or evidence of pulmonary blebs or bullous lung disease. Clinically significant chronic obstructive pulmonary disease, associated with carbon dioxide retention, poorly controlled or associated with acute bronchospasm.
- Where the hyperbaric physician deems the patient to have an otherwise unacceptable risk for hyperbaric chamber exposure
- Claustrophobia
Sites / Locations
- The Mayo Clinic
- Dartmouth-Hitchcock Medical Center
- Prisma Health Richland Hospital
- Wilford Hall Medical Facility
- Hotel Dieu Hospital of Levis
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Group 1
Group 2
Hyperbaric oxygen Hyperbaric chamber
Sham for hyperbaric oxygen Hyperbaric chamber